2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Srf
|
ENSMUSG00000015605.5 | serum response factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Srf | mm10_v2_chr17_-_46556158_46556188 | 0.74 | 5.8e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_85513586 | 1.89 |
ENSMUST00000095759.3
|
Egr4
|
early growth response 4 |
chr2_+_127336152 | 1.86 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr14_+_3652030 | 1.51 |
ENSMUST00000167430.1
|
Gm3020
|
predicted gene 3020 |
chr14_+_3412614 | 1.47 |
ENSMUST00000170123.1
|
Gm10409
|
predicted gene 10409 |
chr14_+_4415448 | 1.39 |
ENSMUST00000168866.1
|
Gm3164
|
predicted gene 3164 |
chr14_+_3049285 | 1.31 |
ENSMUST00000166494.1
|
Gm2897
|
predicted gene 2897 |
chr14_+_4334763 | 1.18 |
ENSMUST00000165466.1
|
2610042L04Rik
|
RIKEN cDNA 2610042L04 gene |
chr14_+_4855576 | 1.18 |
ENSMUST00000166776.1
|
Gm3264
|
predicted gene 3264 |
chr14_-_6287250 | 1.12 |
ENSMUST00000170104.2
|
Gm3411
|
predicted gene 3411 |
chr14_-_7027449 | 1.11 |
ENSMUST00000170738.2
|
Gm10406
|
predicted gene 10406 |
chr14_-_7568566 | 1.08 |
ENSMUST00000163790.1
|
Gm3558
|
predicted gene 3558 |
chr7_+_101896817 | 1.06 |
ENSMUST00000143835.1
|
Anapc15
|
anaphase prompoting complex C subunit 15 |
chr11_-_94973447 | 1.04 |
ENSMUST00000100551.4
ENSMUST00000152042.1 |
Sgca
|
sarcoglycan, alpha (dystrophin-associated glycoprotein) |
chr4_+_148000722 | 1.03 |
ENSMUST00000103230.4
|
Nppa
|
natriuretic peptide type A |
chr14_+_3810074 | 1.02 |
ENSMUST00000170480.1
|
Gm3002
|
predicted gene 3002 |
chr14_+_5501674 | 0.90 |
ENSMUST00000181562.1
|
Gm3488
|
predicted gene, 3488 |
chr18_+_34861200 | 0.89 |
ENSMUST00000165033.1
|
Egr1
|
early growth response 1 |
chr4_-_132351636 | 0.86 |
ENSMUST00000105951.1
|
Rcc1
|
regulator of chromosome condensation 1 |
chr14_-_5389049 | 0.83 |
ENSMUST00000177986.1
|
Gm3500
|
predicted gene 3500 |
chr12_+_86678685 | 0.76 |
ENSMUST00000021681.3
|
Vash1
|
vasohibin 1 |
chr1_-_43163891 | 0.74 |
ENSMUST00000008280.7
|
Fhl2
|
four and a half LIM domains 2 |
chr7_+_101896340 | 0.72 |
ENSMUST00000035395.7
ENSMUST00000106973.1 ENSMUST00000144207.1 |
Anapc15
|
anaphase prompoting complex C subunit 15 |
chr17_+_7925990 | 0.70 |
ENSMUST00000036370.7
|
Tagap
|
T cell activation Rho GTPase activating protein |
chr2_+_125068118 | 0.67 |
ENSMUST00000070353.3
|
Slc24a5
|
solute carrier family 24, member 5 |
chr3_+_68468162 | 0.63 |
ENSMUST00000182532.1
|
Schip1
|
schwannomin interacting protein 1 |
chr3_+_14863495 | 0.63 |
ENSMUST00000029076.4
|
Car3
|
carbonic anhydrase 3 |
chr11_-_12412136 | 0.52 |
ENSMUST00000174874.1
|
Cobl
|
cordon-bleu WH2 repeat |
chr11_-_101424519 | 0.49 |
ENSMUST00000107257.1
ENSMUST00000107259.3 ENSMUST00000107252.2 ENSMUST00000093933.4 |
Gm27029
Ptges3l
|
predicted gene, 27029 prostaglandin E synthase 3 (cytosolic)-like |
chr12_-_103355967 | 0.49 |
ENSMUST00000021617.7
|
Asb2
|
ankyrin repeat and SOCS box-containing 2 |
chr1_-_33757711 | 0.48 |
ENSMUST00000044691.7
|
Bag2
|
BCL2-associated athanogene 2 |
chr14_+_20929416 | 0.47 |
ENSMUST00000022369.7
|
Vcl
|
vinculin |
chr10_-_111997204 | 0.47 |
ENSMUST00000074805.5
|
Glipr1
|
GLI pathogenesis-related 1 (glioma) |
chr14_-_5741577 | 0.47 |
ENSMUST00000177556.1
|
Gm3373
|
predicted gene 3373 |
chr3_+_90072641 | 0.44 |
ENSMUST00000121503.1
ENSMUST00000119570.1 ENSMUST00000062193.9 |
Tpm3
|
tropomyosin 3, gamma |
chr14_-_5880382 | 0.44 |
ENSMUST00000164484.1
|
Gm8237
|
predicted gene 8237 |
chr9_+_75051977 | 0.43 |
ENSMUST00000170310.1
ENSMUST00000166549.1 |
Arpp19
|
cAMP-regulated phosphoprotein 19 |
chr2_+_31759993 | 0.36 |
ENSMUST00000124089.1
|
Abl1
|
c-abl oncogene 1, non-receptor tyrosine kinase |
chr12_-_110695860 | 0.34 |
ENSMUST00000149189.1
|
Hsp90aa1
|
heat shock protein 90, alpha (cytosolic), class A member 1 |
chr7_-_105600103 | 0.31 |
ENSMUST00000033185.8
|
Hpx
|
hemopexin |
chr11_+_33963013 | 0.30 |
ENSMUST00000020362.2
|
Kcnmb1
|
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
chr5_-_112896350 | 0.28 |
ENSMUST00000086617.4
|
Myo18b
|
myosin XVIIIb |
chr1_+_63176818 | 0.27 |
ENSMUST00000129339.1
|
Eef1b2
|
eukaryotic translation elongation factor 1 beta 2 |
chr4_+_132351768 | 0.26 |
ENSMUST00000172202.1
|
Gm17300
|
predicted gene, 17300 |
chr12_-_110696248 | 0.26 |
ENSMUST00000124156.1
|
Hsp90aa1
|
heat shock protein 90, alpha (cytosolic), class A member 1 |
chr6_+_113378113 | 0.25 |
ENSMUST00000171058.1
ENSMUST00000156898.1 |
Arpc4
|
actin related protein 2/3 complex, subunit 4 |
chr17_-_46153517 | 0.25 |
ENSMUST00000171172.1
|
Mad2l1bp
|
MAD2L1 binding protein |
chr12_-_110696289 | 0.25 |
ENSMUST00000021698.6
|
Hsp90aa1
|
heat shock protein 90, alpha (cytosolic), class A member 1 |
chr15_-_77842133 | 0.24 |
ENSMUST00000016771.6
|
Myh9
|
myosin, heavy polypeptide 9, non-muscle |
chr14_-_7174533 | 0.24 |
ENSMUST00000172431.1
|
Gm3512
|
predicted gene 3512 |
chr5_-_145191511 | 0.24 |
ENSMUST00000161845.1
|
Atp5j2
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2 |
chr15_-_76229492 | 0.24 |
ENSMUST00000074834.5
|
Plec
|
plectin |
chr12_+_85473883 | 0.23 |
ENSMUST00000021674.6
|
Fos
|
FBJ osteosarcoma oncogene |
chr2_+_154548888 | 0.23 |
ENSMUST00000045116.4
ENSMUST00000109709.3 |
1700003F12Rik
|
RIKEN cDNA 1700003F12 gene |
chr7_-_19310035 | 0.23 |
ENSMUST00000003640.2
|
Fosb
|
FBJ osteosarcoma oncogene B |
chr3_-_95891938 | 0.22 |
ENSMUST00000036360.6
ENSMUST00000090476.3 |
BC028528
|
cDNA sequence BC028528 |
chr8_+_15057646 | 0.21 |
ENSMUST00000033842.3
|
Myom2
|
myomesin 2 |
chr7_+_119895836 | 0.19 |
ENSMUST00000106518.1
ENSMUST00000054440.3 |
Lyrm1
|
LYR motif containing 1 |
chr14_-_45529964 | 0.18 |
ENSMUST00000150660.1
|
Fermt2
|
fermitin family homolog 2 (Drosophila) |
chr7_+_119896292 | 0.18 |
ENSMUST00000106517.1
|
Lyrm1
|
LYR motif containing 1 |
chr4_+_43957401 | 0.18 |
ENSMUST00000030202.7
|
Glipr2
|
GLI pathogenesis-related 2 |
chr15_-_36794498 | 0.17 |
ENSMUST00000110361.1
ENSMUST00000022894.7 ENSMUST00000110359.1 |
Ywhaz
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
chr7_+_120677579 | 0.17 |
ENSMUST00000060175.6
|
BC030336
|
cDNA sequence BC030336 |
chr14_+_55575617 | 0.15 |
ENSMUST00000022826.5
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr3_-_95891929 | 0.15 |
ENSMUST00000171519.1
|
BC028528
|
cDNA sequence BC028528 |
chr1_-_131097535 | 0.14 |
ENSMUST00000016672.4
|
Mapkapk2
|
MAP kinase-activated protein kinase 2 |
chr12_-_80968075 | 0.14 |
ENSMUST00000095572.4
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr3_-_19311269 | 0.14 |
ENSMUST00000099195.3
|
Pde7a
|
phosphodiesterase 7A |
chr7_-_142661858 | 0.13 |
ENSMUST00000145896.2
|
Igf2
|
insulin-like growth factor 2 |
chr1_+_67123015 | 0.13 |
ENSMUST00000027144.7
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chrX_+_11321423 | 0.13 |
ENSMUST00000178196.1
|
Gm14478
|
predicted gene 14478 |
chr17_-_46556158 | 0.12 |
ENSMUST00000015749.5
|
Srf
|
serum response factor |
chr9_-_66514567 | 0.12 |
ENSMUST00000056890.8
|
Fbxl22
|
F-box and leucine-rich repeat protein 22 |
chrX_+_11308824 | 0.12 |
ENSMUST00000178595.1
|
Gm14476
|
predicted gene 14476 |
chr2_+_69380431 | 0.12 |
ENSMUST00000063690.3
|
Dhrs9
|
dehydrogenase/reductase (SDR family) member 9 |
chr3_-_152266320 | 0.11 |
ENSMUST00000046045.8
|
Nexn
|
nexilin |
chr2_-_60673654 | 0.11 |
ENSMUST00000059888.8
ENSMUST00000154764.1 |
Itgb6
|
integrin beta 6 |
chrX_+_11324659 | 0.11 |
ENSMUST00000164729.2
|
Gm14475
|
predicted gene 14475 |
chr14_+_74732384 | 0.11 |
ENSMUST00000176957.1
|
Esd
|
esterase D/formylglutathione hydrolase |
chr16_+_11313812 | 0.11 |
ENSMUST00000023140.5
|
Tnfrsf17
|
tumor necrosis factor receptor superfamily, member 17 |
chr14_-_54966570 | 0.10 |
ENSMUST00000124930.1
ENSMUST00000134256.1 ENSMUST00000081857.6 ENSMUST00000145322.1 |
Myh6
|
myosin, heavy polypeptide 6, cardiac muscle, alpha |
chr2_+_127208358 | 0.10 |
ENSMUST00000103220.3
|
Snrnp200
|
small nuclear ribonucleoprotein 200 (U5) |
chr1_+_78816909 | 0.10 |
ENSMUST00000057262.6
|
Kcne4
|
potassium voltage-gated channel, Isk-related subfamily, gene 4 |
chrX_+_11315158 | 0.09 |
ENSMUST00000179004.1
|
Gm14479
|
predicted gene 14479 |
chr5_+_24413406 | 0.09 |
ENSMUST00000049346.5
|
Asic3
|
acid-sensing (proton-gated) ion channel 3 |
chr11_-_99493112 | 0.09 |
ENSMUST00000006969.7
|
Krt23
|
keratin 23 |
chr11_-_5898771 | 0.08 |
ENSMUST00000102921.3
|
Myl7
|
myosin, light polypeptide 7, regulatory |
chr5_-_142905928 | 0.08 |
ENSMUST00000106216.2
|
Actb
|
actin, beta |
chr7_+_19131686 | 0.07 |
ENSMUST00000165913.1
|
Fbxo46
|
F-box protein 46 |
chr18_+_45268876 | 0.07 |
ENSMUST00000183850.1
ENSMUST00000066890.7 |
Kcnn2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr16_-_4880284 | 0.07 |
ENSMUST00000037843.6
|
Ubald1
|
UBA-like domain containing 1 |
chr2_-_152415044 | 0.07 |
ENSMUST00000099207.3
|
Zcchc3
|
zinc finger, CCHC domain containing 3 |
chr4_+_43957678 | 0.07 |
ENSMUST00000107855.1
|
Glipr2
|
GLI pathogenesis-related 2 |
chr8_-_71381907 | 0.07 |
ENSMUST00000002466.8
|
Nr2f6
|
nuclear receptor subfamily 2, group F, member 6 |
chrX_-_79434418 | 0.07 |
ENSMUST00000179788.1
|
Chdc2
|
calponin homology domain containing 2 |
chr14_-_78308031 | 0.07 |
ENSMUST00000022592.7
|
Tnfsf11
|
tumor necrosis factor (ligand) superfamily, member 11 |
chrX_-_166518567 | 0.06 |
ENSMUST00000112187.1
|
Tceanc
|
transcription elongation factor A (SII) N-terminal and central domain containing |
chr11_-_120731944 | 0.06 |
ENSMUST00000154565.1
ENSMUST00000026148.2 |
Cbr2
|
carbonyl reductase 2 |
chr11_-_70669283 | 0.06 |
ENSMUST00000129434.1
ENSMUST00000018431.6 |
Spag7
|
sperm associated antigen 7 |
chr19_+_5447692 | 0.06 |
ENSMUST00000025850.5
|
Fosl1
|
fos-like antigen 1 |
chr13_+_109260481 | 0.05 |
ENSMUST00000153234.1
|
Pde4d
|
phosphodiesterase 4D, cAMP specific |
chr6_-_83536215 | 0.05 |
ENSMUST00000075161.5
|
Actg2
|
actin, gamma 2, smooth muscle, enteric |
chr11_-_70687917 | 0.04 |
ENSMUST00000108545.2
ENSMUST00000120261.1 ENSMUST00000036299.7 ENSMUST00000119120.1 ENSMUST00000100933.3 |
Camta2
|
calmodulin binding transcription activator 2 |
chr11_+_101331069 | 0.03 |
ENSMUST00000017316.6
|
Aoc3
|
amine oxidase, copper containing 3 |
chr19_-_4928241 | 0.02 |
ENSMUST00000025851.3
|
Dpp3
|
dipeptidylpeptidase 3 |
chr11_-_69662564 | 0.02 |
ENSMUST00000129224.1
ENSMUST00000155200.1 |
Mpdu1
|
mannose-P-dolichol utilization defect 1 |
chr14_-_6889962 | 0.02 |
ENSMUST00000171906.1
|
Gm3667
|
predicted gene 3667 |
chrX_+_11311934 | 0.02 |
ENSMUST00000178979.1
|
Gm14484
|
predicted gene 14484 |
chr14_-_76010863 | 0.02 |
ENSMUST00000088922.4
|
Gtf2f2
|
general transcription factor IIF, polypeptide 2 |
chr4_-_63403330 | 0.01 |
ENSMUST00000035724.4
|
Akna
|
AT-hook transcription factor |
chr2_+_31759932 | 0.00 |
ENSMUST00000028190.6
|
Abl1
|
c-abl oncogene 1, non-receptor tyrosine kinase |
chr5_-_26089291 | 0.00 |
ENSMUST00000094946.4
|
Gm10471
|
predicted gene 10471 |
chr11_+_101330605 | 0.00 |
ENSMUST00000103105.3
|
Aoc3
|
amine oxidase, copper containing 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.3 | 0.9 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.3 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 0.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.8 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.4 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.1 | 1.8 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.0 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.0 | 0.6 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.0 | 1.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.1 | GO:0071847 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 1.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) myosin II filament(GO:0097513) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 1.0 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.8 | GO:0002135 | CTP binding(GO:0002135) |
0.1 | 0.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 1.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 0.1 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 3.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |